SCHEMBL4746671

SCHEMBL4746671

COc1cc(Cl)cc(Cl)c1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
HPGD P15428 1/20 0.54
MAPT P10636 3/20 0.54
CNR1 P21554 1/20 0.54
RAB9A P51151 2/20 0.53
TTR P02766 1/20 0.49
KDM4E B2RXH2 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
RORC P51449 1/20 0.47
LMNA P02545 3/20 0.47
ADRB2 P07550 1/20 0.45
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746727 0.79 HPGD (0.68) POLBHPGDMAPTCNR1RAB9A
SCHEMBL3233109 0.79 ERN1 (0.47) HPGDMAPTTTRKDM4ERORC
SCHEMBL3028435 0.79 KDM4E (0.47) HPGDMAPTTTRKDM4ERORC
Hydrochloric Acid SCHEMBL10398546 0.77 KDM4E (0.46) HPGDMAPTTTRKDM4ERORC
SCHEMBL17351004 0.77 KDM4E (0.42) POLBHPGDMAPTTTRKDM4E
SCHEMBL17063602 0.77 GAA (0.47) HPGDMAPTKDM4ELMNACYP3A4
SCHEMBL29772213 0.76 CYP1A2 (0.79) POLBHPGDMAPTCNR1TTR
SCHEMBL6839373 0.76 CYP1A2 (0.79) POLBHPGDMAPTCNR1TTR
SCHEMBL4745371 0.75 CNR1 (0.54) HPGDCNR1CYP3A4TSHRALOX15
SCHEMBL31443266 0.75 CNR1 (0.67) POLBHPGDMAPTCNR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008107320-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS CEREP (FR) 2008-09-12 WO disclosed